GENE ONLINE|News &
Opinion
Blog

Innovation
R&D
BioMarin Collaborates with Canadian Biotech for AI-based Drug Discovery
2020-11-22
Technology Cancer
Novel Lipid Nanoparticle Delivery System Enables CRISPR Gene Editing to Combat Cancer
2020-11-22
R&D Immunotherapy
Spotlight: Cholesterol Reducing Drugs Could Potentially Augment Cancer Immunotherapy
2020-11-22
Technology CRISPR
Eli Lilly Forays into Gene Editing with Precision BioSciences Collaboration
2020-11-21
R&D LDL
Regeneron’s Antibody Therapy Reduces LDL Cholesterol in Hypercholesterolemia Patients
2020-11-21
Manufacturing Antibody Therapy
Lilly Partners with Samsung Biologics to Boost Delivery of COVID-19 Antibody Treatments
2020-11-19
Licensing
FMI Empowers its Genomic Cancer Testing by Licensing TwinStrand’s Duplex Sequencing Technology
2020-11-18
R&D DNA Database
Genomics Companies Form an Alliance with Microsoft for DNA Data Storage
2020-11-17
Technology Marine Biology
CRISPR Helps Identify Key Heat Tolerance Gene in Corals
2020-11-17
Technology PTSD
FDA Allows Marketing of New Device to Reduce Nightmare-Related Sleep Disturbances in Adults
2020-11-13
Trials & Approvals Atopic Dermatitis
Pfizer’s JAK1 Inhibitor Impresses in Phase 3 Atopic Dermatitis Trial
2020-11-12
R&D TNF
Prometheus Bags $130 Million to Develop Precision Medicines for IBD Treatment
2020-11-10
In-Depth Cas9
CRISPR/Cas9 Gene Editing in Cell and Gene Therapies
2020-11-08
Technology Gene Editing
New Study Demonstrates Undesired Effects of CRISPR Gene Editing in Human Embryo
2020-11-01
Technology Neuroprotection
Newly Discovered Immune Cells can Help Fight CNS Damage
2020-11-01
1 … 36 37 38 39 40 … 58
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top